Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers

Cancer Letters

Volumn 239, Issue 2, 2006, Pages 246-253

  Ohta, Toshihisa ^a   Takahashi, Mami ^b   Ochiai, Atsushi ^b  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cyclooxygenase 2; Human colon cancer; Immunohistochemical staining; Inducible nitric oxide synthase; Western blot analysis

Indexed keywords

CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COLON CANCER; COLON CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG TARGETING; ENZYME ANALYSIS; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR CELL;

ADULT; AGED; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; TUMOR CELLS, CULTURED;

EID: 33745676331     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.08.014     Document Type: Article

References (32)

1. Schmidt H.H., and Walter U. NO at work. Cell 78 (1994) 919-925
2. Förstermann U., and Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms, Naunyn-Schmiedeberg's. Arch. Pharmacol. 352 (1995) 351-364
3. Förstermann U., Closs E.I., Pollock J.S., Nakane M., Schwarz P., Gath I., and Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23 (1994) 1121-1131
4. Ohshima H., and Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305 (1994) 253-264
5. Buttery L.D., Springall D.R., Andrade S.P., Riveros-Moreno V., Hart I., Piper P.J., and Polak J.M. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J. Pathol. 171 (1993) 311-319
6. Maeda H., Noguchi Y., Sato K., and Akaike T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn. J. Cancer Res. 85 (1994) 331-334
7. Takahashi M., Fukuda K., Ohata T., Sugimura T., and Wakabayashi K. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res. 57 (1997) 1233-1237
8. Chhatwal V.J., Ngoi S.S., Chan S.T., Chia Y.W., and Moochhala S.M. Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa. Carcinogenesis 15 (1994) 2081-2085
9. Moochhala S., Chhatwal V.J., Chan S.T., Ngoi S.S., Chia Y.W., and Rauff A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 17 (1996) 1171-1174
10. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58 (1998) 334-341
11. Kojima M., Morisaki T., Tsukahara Y., Uchiyama A., Matsunari Y., Mibu R., and Tanaka M. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J. Surg. Oncol. 70 (1999) 222-229
12. Yagihashi N., Kasajima H., Sugai S., Matsumoto K., Ebina Y., Morita T., et al. Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch. 436 (2000) 109-114
13. Wendum D., Masliah J., Trugnan G., and Flejou J.F. Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch. 445 (2004) 327-333
14. Thun M.J., Henley S.J., and Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 94 (2002) 252-266
15. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
16. Mann J.R., and DuBois R.N. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J. 10 (2004) 145-152
17. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl Acad. Sci. U S A 90 (1993) 7240-7244
18. Cianchi F., Cortesini C., Fantappie O., Messerini L., Sardi I., Lasagna N., et al. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin. Cancer Res. 10 (2004) 2694-2704
19. Bing R.J., Miyataka M., Rich K.A., Hanson N., Wang X., Slosser H.D., and Shi S.R. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. Clin. Cancer Res. 7 (2001) 3385-3392
20. Takahashi M., Mutoh M., Kawamori T., Sugimura T., and Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 21 (2000) 1319-1327
21. Nozoe T., Yasuda M., Honda M., Inutsuka S., and Korenaga D. Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma. Oncol. Rep. 9 (2002) 521-524
22. Lagares-Garcia J.A., Moore R.A., Collier B., Heggere M., Diaz F., and Qian F. Nitric oxide synthase as a marker in colorectal carcinoma. Am. Surg. 67 (2001) 709-713
23. Ropponen K.M., Kellokoski J.K., Lipponen P.K., Eskelinen M.J., Alanne L., Alhava E.M., and Kosma V.M. Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis. Scand. J. Gastroenterol. 35 (2000) 1204-1211
24. Sheehan K.M., Sheahan K., O'Donoghue D.P., MacSweeney F., Conroy R.M., Fitzgerald D.J., and Murray F.E. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 282 (1999) 1254-1257
25. Zhang H., and Sun X.F. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am. J. Gastroenterol. 97 (2002) 1037-1041
26. Nosho K., Yoshida M., Yamamoto H., Taniguchi H., Adachi Y., Mikami M., et al. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. Carcinogenesis 26 (2005) 892-899
27. van der Woude C.J., Kleibeuker J.H., Jansen P.L., and Moshage H. Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract. Apoptosis 9 (2004) 123-130
28. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., and Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111 (1996) 871-885
29. Singer I.I., Kawka D.W., Schloemann S., Tessner T., Riehl T., and Stenson W.F. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115 (1998) 297-306
30. Kado S., Uchida K., Funabashi H., Iwata S., Nagata Y., Ando M., et al. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res. 61 (2001) 2395-2398
31. Rao C.V., Kawamori T., Hamid R., and Reddy B.S. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 20 (1999) 641-644
32. Kawamori T., Takahashi M., Watanabe K., Ohta T., Nakatsugi S., Sugimura T., and Wakabayashi K. Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor. Cancer Lett. 148 (2000) 33-37